István Molnár

2.9k citations
45 papers · 2.1k · 1 hit paper · h-index 18

Impact in

Papers in

István Molnár

43 papers receiving 2.1k citations

István Molnár's Hit Papers

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 2014 · 1.2k citations
1.2k0+4+8Years since publication2505007501000

Peers

István Molnár
Comparison fields: 5 of 95
  • Endocrinology, Diabetes and Metabolism 1.0k
  • Oncology 453
  • Hematology 170
  • Internal Medicine 48
  • Genetics 110
Replace Jay Wasman with:
Jay Wasman United States
Fabio A.B. Schutz United States
H. Richard Alexander United States
Mario V. Fiorentino Italy
Michael T. Stang United States
Giles F. Whalen United States
Yang Yao China
Antonio Piñero Spain
Wei‐Xiang Qi China
Leopold Balleisen Germany
István Molnár relative to Jay Wasman United States Jay Wasman's profile →
Citations per field
00.5×
Jay Wasman · 1×
Citations per year

Countries citing papers authored by István Molnár

Since Specialization
Citations

This map shows the geographic impact of István Molnár's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Molnár with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Molnár more than expected).

Fields of papers citing papers by István Molnár

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by István Molnár. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Molnár. The network helps show where István Molnár may publish in the future.

Co-authors

The 25 scholars most cited alongside István Molnár, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with István Molnár Line = papers co-authored together István Molnár links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Hit paper breakdown →
20141171
2 2016126
3 201897
4 200474
5 201361
6 200760
7 201746
8 201341
9 201341
10 199239
11 200833
12 200931
13 198828
14 201427
15 201125
16 198825
17 201524
18 200723
19 201917
20 200814

About István Molnár

István Molnár is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Hematology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (4 papers), Trace Elements in Health (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Iron Metabolism and Disorders (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Oncology (453 citations), Hematology (170 citations), Internal Medicine (48 citations) and Genetics (110 citations). István Molnár has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Barbara Jarząb, Rossella Elisei, Christelle de la Fouchardière, Young Kee Shong, Lars Bastholt, Johannes W. A. Smit, Salvatore Siena, Steven I. Sherman, Marcia S. Brose and Furio Pacini. Their work appears in journals such as Journal of Clinical Oncology, Experimental and Clinical Endocrinology & Diabetes, Blood, Thrombosis Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact